| Reg. číslo | Kód | Liek / Účinná látka | Doplnok | Držiteľ |
|---|---|---|---|---|
| 18/0001/24-S | 5222E | Ansifora Duo 50 mg/1 000 mg filmom obalené tablety | tbl flm 112x50 mg/1 000 mg (blis.PVC/PE/PVDC/Al) | VIH-PL-1 |
| 18/0001/24-S | 5221E | Ansifora Duo 50 mg/1 000 mg filmom obalené tablety | tbl flm 60x50 mg/1 000 mg (blis.PVC/PE/PVDC/Al) | VIH-PL-1 |
| 18/0001/24-S | 5220E | Ansifora Duo 50 mg/1 000 mg filmom obalené tablety | tbl flm 56x50 mg/1 000 mg (blis.PVC/PE/PVDC/Al) | VIH-PL-1 |
| 18/0001/24-S | 5219E | Ansifora Duo 50 mg/1 000 mg filmom obalené tablety | tbl flm 28x50 mg/1 000 mg (blis.PVC/PE/PVDC/Al) | VIH-PL-1 |
| 18/0071/23-S | 3301E | Ansifora 100 mg filmom obalené tablety | tbl flm 98x100 mg (blis.OPA/Al/PVC/Al) | VIH-PL-1 |
| 18/0071/23-S | 3299E | Ansifora 100 mg filmom obalené tablety | tbl flm 84x100 mg (blis.OPA/Al/PVC/Al) | VIH-PL-1 |
| 18/0071/23-S | 3298E | Ansifora 100 mg filmom obalené tablety | tbl flm 56x100 mg (blis.OPA/Al/PVC/Al) | VIH-PL-1 |
| 18/0071/23-S | 3296E | Ansifora 100 mg filmom obalené tablety | tbl flm 28x100 mg (blis.OPA/Al/PVC/Al) | VIH-PL-1 |